SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-152292
Filing Date
2016-10-27
Accepted
2016-10-27 06:02:29
Documents
70
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-17213_110q.htm 10-Q 1431210
2 EX-10.1 a16-17213_1ex10d1.htm EX-10.1 9403
3 EX-31.1 a16-17213_1ex31d1.htm EX-31.1 16214
4 EX-31.2 a16-17213_1ex31d2.htm EX-31.2 16145
5 EX-32.1 a16-17213_1ex32d1.htm EX-32.1 7543
6 EX-32.2 a16-17213_1ex32d2.htm EX-32.2 7541
  Complete submission text file 0001104659-16-152292.txt   7008873

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT uthr-20160930.xml EX-101.INS 1740975
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20160930.xsd EX-101.SCH 49182
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20160930_cal.xml EX-101.CAL 71475
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20160930_def.xml EX-101.DEF 206146
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT uthr-20160930_lab.xml EX-101.LAB 488051
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20160930_pre.xml EX-101.PRE 350738
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 161953760
SIC: 2834 Pharmaceutical Preparations